Assessment of thrombogenicity of prothrombin complex concentrates in a porcine model
- 1 April 1985
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 38 (2), 173-188
- https://doi.org/10.1016/0049-3848(85)90059-3
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Fatal Myocardial Necrosis Associated with Prothrombin-Complex–Concentrate Therapy in Hemophilia ANew England Journal of Medicine, 1983
- Comparison between two concentrates with factor VIII inhibitor bypassing activityThrombosis Research, 1982
- Acute myocardial infarction in a young hemophiliac patient during therapy with Factor IX concentrate and epsilon aminocaproic acidThe Journal of Pediatrics, 1981
- PROTHROMBIN COMPLEX CONCENTRATES: CLINICAL USE*Annals of the New York Academy of Sciences, 1981
- Myocardial infarction after factor IX therapyPublished by American Medical Association (AMA) ,1981
- Hazards of Prothrombin-Complex Concentrates in Treatment of HemophiliaNew England Journal of Medicine, 1981
- The thrombogenicity of prothrombin complex concentrates: II. The effect of thrombocytopenia on in vivo thrombogenicity in rabbitsThrombosis Research, 1980
- Thrombogenicity of Factor IX Concentrates: in vitro and in vivo (Rabbit) StudiesVox Sanguinis, 1978
- Therapy with Factor IX Concentrate Resulting in DIC and Thromboembolic PhenomenaTransfusion, 1978
- Prothrombin-Complex Concentrates and ThrombosesNew England Journal of Medicine, 1974